-transparent.png){kind=logo}
Dimethylhydrazine has been used to produce colonic tumours in mice. If sulindac, a non-steroidal anti-inflammatory drug, is administered simultaneously fewer microadenomata and fewer macroscopic tumours are produced. Those which do appear are comparable in size to the ones in the mice which do not receive sulindac. Sulindac therefore appears to exert an anti-tumour influence at the stage between dysplasia and the formation of microadenomata.
Related Publications
M Moorghen, and
P Ince, and
K J Finney, and
J P Sunter, and
A J Watson, and
D R Appleton
July 1984,
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
M Moorghen, and
P Ince, and
K J Finney, and
J P Sunter, and
A J Watson, and
D R Appleton
April 1980,
Cancer research,
M Moorghen, and
P Ince, and
K J Finney, and
J P Sunter, and
A J Watson, and
D R Appleton
April 1995,
Gastroenterology,
M Moorghen, and
P Ince, and
K J Finney, and
J P Sunter, and
A J Watson, and
D R Appleton
May 1982,
Acta pathologica japonica,
M Moorghen, and
P Ince, and
K J Finney, and
J P Sunter, and
A J Watson, and
D R Appleton
July 1981,
Cancer research,
M Moorghen, and
P Ince, and
K J Finney, and
J P Sunter, and
A J Watson, and
D R Appleton
July 1980,
British journal of cancer,
M Moorghen, and
P Ince, and
K J Finney, and
J P Sunter, and
A J Watson, and
D R Appleton
March 2000,
The Journal of nutrition,
M Moorghen, and
P Ince, and
K J Finney, and
J P Sunter, and
A J Watson, and
D R Appleton
April 1978,
British journal of cancer,
M Moorghen, and
P Ince, and
K J Finney, and
J P Sunter, and
A J Watson, and
D R Appleton
June 1974,
British journal of cancer,
M Moorghen, and
P Ince, and
K J Finney, and
J P Sunter, and
A J Watson, and
D R Appleton
April 1990,
Cancer,
